In a groundbreaking milestone for medical science, a New Hampshire man has set a world record by surviving 271 days with a genetically modified pig kidney before successfully receiving a human donor organ. The case of 68-year-old Tim Andrews demonstrates that cross-species organ transplantation—known as xenotransplantation—can effectively sustain human life and serve as a temporary bridge for patients suffering from end-stage renal disease. Details of the historic trial, performed at Mass General Brigham in Boston, were published in the prestigious medical journal The Lancet. Physicians confirmed that Andrews spent nearly nine months completely free from dialysis before transitioning to a human transplant, offering unprecedented hope to hundreds of thousands of patients worldwide who face agonizing delays on organ waiting lists.
A Pioneer's Leap for Xenotransplantation
Andrews, a retired grocery store manager from Barrington, New Hampshire, initially received the modified porcine organ on January 25, 2025, when he was 66 years old. Suffering from severe renal failure, he had believed his end was near and voluntarily offered to participate in the experimental trial primarily to advance scientific understanding. Medical professionals led by Dr. Leonardo Riella monitored his progress closely as the engineered kidney maintained normal filtration functions inside Andrews' body. Hospital officials noted that this clinical trial marks the longest documented period of dialysis-free survival following a porcine kidney transplant into a living human host, proving that animal organs can safely preserve physiological stability over extended periods without immediate rejection.
Before Andrews achieved this benchmark, experimental animal organ transplants had demonstrated limited longevity in clinical settings. The first recipient of a modified pig kidney, Richard Slayman, survived for 52 days in 2024 before succumbing to unrelated cardiac complications while his transplanted organ was still functioning. Later, 55-year-old Towana Looney maintained a pig kidney for 130 days at NYU Langone Health before immune rejection necessitated its removal in April 2025. Andrews’ achievement far exceeded those previous durations, illustrating that refined genetic edits and customized immunosuppressive regimes can effectively mitigate acute hyper-rejection. By remaining off dialysis for 271 consecutive days, Andrews confirmed the viability of porcine organs as stable intermediate therapies.
Addressing the Critical Shortage of Human Donor Organs
The success of Andrews' treatment addresses an acute crisis within global healthcare systems: the severe scarcity of human donor organs. Currently, more than 100,000 individuals in the United States remain on national organ transplant waiting lists, with the overwhelming majority awaiting viable kidneys. Many individuals die while waiting for matching donors, as demand constantly outstrips available supplies. According to Dr. Riella, xenotransplantation presents a viable solution to bridge this vital gap. Physicians envision utilizing genetically modified animal organs as temporary measures to keep critical patients stable off dialysis, or eventually, as permanent replacement therapies once long-term safety, durability, and immune tolerance are comprehensively established.
Medical researchers previously estimated that broad clinical adoption of xenotransplantation was at least a decade away from becoming standard medical practice. However, given the success seen in Andrews’ case, specialists now suggest that pig kidney transplants could become widely accessible within five years or less. This accelerated timeline could radically reshape standard treatment protocols for chronic kidney failure. Rather than facing years of exhausting dialysis treatments while waiting for a matching deceased donor, patients suffering from renal failure may soon be able to receive genetically tailored animal organs on demand, stabilizing their metabolic function until a permanent human organ becomes readily available.
The Successful Transition to a Human Organ
What makes Andrews' medical journey particularly notable is that it represents the first documented case of a patient transitioning from a porcine xenotransplant to a standard human organ transplant. After 271 days supported by the pig kidney, Andrews was matched with a compatible human donor and underwent surgery to complete the transfer. Clinicians report that his body responded exceptionally well to the human organ, which is currently operating with optimal efficiency. Doctors indicate that Andrews could potentially enjoy decades of healthy life ahead. Andrews expressed profound gratitude for the young donor whose organ saved his life, while noting a curious personal shift—developing an unexpected fondness for blueberries, a fruit favored by his donor.
Renewed Hope and Quality of Life
For Andrews, a father of three adult children, surviving this pioneering experiment has yielded a completely new perspective on everyday existence. Having entered the study under the assumption that his life was nearing its conclusion, he now embraces daily physical activities including swimming, cycling, and fishing, along with spending time outdoors in New Hampshire. He noted that every new day feels like a precious gift after facing imminent mortality just two years prior. His willingness to participate in experimental medicine has provided researchers with invaluable biological data, opening doors for prospective candidates who previously had few alternatives outside of grueling, continuous dialysis routines.
The Road Ahead for Cross-Species Medicine
As surgical teams analyze the data gathered throughout Andrews' 271-day journey, regulatory bodies and medical institutions are assessing the next steps for expanded clinical trials. The integration of advanced genetic modifications—designed to prevent cellular rejection and deactivate latent viral elements—has dramatically improved organ compatibility. Medical centers around the globe are taking note of Mass General Brigham's methodology, paving the way for standardized procedures in xenotransplantation. While challenges surrounding long-term immune tolerance remain to be fully evaluated, Andrews' case stands as a historic proof of concept, demonstrating that engineered animal organs can successfully preserve human life during the critical wait for human donors.
